Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.551
-0.009 (-1.68%)
At close: Oct 29, 2024, 4:00 PM
0.560
+0.010 (1.76%)
After-hours: Oct 29, 2024, 7:59 PM EDT
Catheter Precision Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.44 | 0.44 | 0.01 | 0.02 | 0.26 |
| Revenue Growth (YoY) | 140.88% | 3057.14% | -36.36% | -91.51% | - |
| Cost of Revenue | 0.03 | 0.03 | 0.16 | 1.56 | 2.17 |
| Gross Profit | 0.4 | 0.41 | -0.15 | -1.54 | -1.91 |
| Selling, General & Admin | 10.84 | 17.12 | 16.25 | 15.48 | 24.53 |
| Research & Development | 0.22 | 0.48 | 6.39 | 12.25 | 8.96 |
| Operating Expenses | 11.06 | 17.6 | 22.64 | 27.73 | 33.49 |
| Operating Income | -10.66 | -17.19 | -22.79 | -29.27 | -35.4 |
| Interest & Investment Income | 0.19 | 0.35 | - | - | - |
| Other Non Operating Income (Expenses) | 0.98 | 7.2 | 0.1 | -0.01 | 0.09 |
| EBT Excluding Unusual Items | -9.49 | -9.64 | -22.69 | -29.28 | -35.31 |
| Merger & Restructuring Charges | - | - | -4.17 | - | - |
| Impairment of Goodwill | - | -60.93 | - | - | - |
| Other Unusual Items | - | - | - | 2.02 | - |
| Pretax Income | -9.49 | -70.57 | -26.86 | -27.26 | -35.31 |
| Income Tax Expense | - | - | 0 | 0 | 0.01 |
| Earnings From Continuing Operations | -9.49 | -70.57 | -26.87 | -27.26 | -35.32 |
| Earnings From Discontinued Operations | - | - | - | 2.19 | -0.73 |
| Net Income | -9.49 | -70.57 | -26.87 | -25.07 | -36.05 |
| Preferred Dividends & Other Adjustments | - | 0.8 | - | - | - |
| Net Income to Common | -9.49 | -71.37 | -26.87 | -25.07 | -36.05 |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | - |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | - |
| Shares Change (YoY) | 158.09% | 431.53% | 923.58% | - | - |
| EPS (Basic) | -13.15 | -129.88 | -259.86 | -2482.18 | - |
| EPS (Diluted) | -13.15 | -129.88 | -259.86 | -2482.18 | - |
| Free Cash Flow | -7.44 | -20.7 | -22.59 | -27.89 | -28.37 |
| Free Cash Flow Per Share | -10.31 | -37.66 | -218.46 | -2761.39 | - |
| Gross Margin | 92.20% | 93.21% | - | - | - |
| Operating Margin | -2444.95% | -3888.01% | -162778.57% | -133027.27% | -13668.34% |
| Profit Margin | -2176.83% | -16147.51% | -191892.86% | -113954.55% | -13916.99% |
| Free Cash Flow Margin | -1707.34% | -4682.13% | -161321.43% | -126772.73% | -10954.05% |
| EBITDA | -8.58 | -15.11 | -22.37 | -28.1 | -33.44 |
| D&A For EBITDA | 2.09 | 2.08 | 0.42 | 1.17 | 1.97 |
| EBIT | -10.66 | -17.19 | -22.79 | -29.27 | -35.4 |
| Revenue as Reported | - | - | - | - | 0.26 |
Source: S&P Capital IQ. Standard template.
Financial Sources.